InsiderTrades

Form 4 for LAB STANDARD BIOTOOLS INC.

Accepted 2024-04-05 00:00:00 ET · period of report 2024-04-04 · accession 0000950170-24-042372 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-05 2024-04-05 LAB Kim Hanjoon Alex COO A - Grant $0.00 +70.7K 211.1K +50% $0
D 2024-04-05 2024-04-04 LAB Kim Hanjoon Alex COO M - OptEx $0.00 +70.2K 140.4K +100% $0
D 2024-04-05 2024-04-04 LAB Kim Hanjoon Alex COO M - OptEx $0.00 -70.2K 140.4K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-05 A A 70,702 $0.00 211,068 D — — (F1) On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024.
2 Common Common Stock 2024-04-04 M A 70,183 $0.00 140,366 D — —
3 Derivative Restricted Stock Units 2024-04-04 M D 70,183 $0.00 140,366 D — · — to — 70,183 Common Stock (F2) Each RSU represents the contingent right to receive one share of the Issuer's common stock. (F3) On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.